Insights

Innovative Diagnostics Tollo Health specializes in proprietary diagnostic technologies, including the patented TBIA platform and CE-marked cancer screening tests, positioning the company to meet growing demand for advanced early detection solutions in oncology and neurodegenerative disorders.

Expanding Test Portfolio With ongoing development of blood tests for cancer, Alzheimer's, and infectious diseases like COVID-19, Tollo offers multiple revenue streams and opportunities to collaborate with healthcare providers seeking comprehensive screening options.

Strategic Acquisitions The acquisition of Provista Diagnostics enhances Tollo's diagnostic capabilities and access to established CLIA/CAP-certified labs, opening avenues to sell complementary lab services and integrated testing solutions for clinical partners.

Patent & IP Growth Recent patent allowances from USPTO for their infrared analysis platform demonstrate strong intellectual property position, enabling potential licensing agreements and partnerships with global biotech and diagnostic companies.

Market Expansion Potential Tollo's focus on international markets along with collaborations for COVID-19 test distribution presents sales opportunities in global health crises, especially in markets requiring early detection tools for emerging infectious and chronic diseases.

Tollo Health Tech Stack

Tollo Health uses 8 technology products and services including WordPress, RSS, Google Fonts API, and more. Explore Tollo Health's tech stack below.

  • WordPress
    Content Management System
  • RSS
    Content Management System
  • Google Fonts API
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • Apache
    Web Servers

Media & News

Tollo Health's Email Address Formats

Tollo Health uses at least 2 format(s):
Tollo Health Email FormatsExamplePercentage
First.L@todosmedical.comJohn.D@todosmedical.com
67%
First@todosmedical.comJohn@todosmedical.com
16%
Last@todosmedical.comDoe@todosmedical.com
9%
First.Last@todosmedical.comJohn.Doe@todosmedical.com
8%

Frequently Asked Questions

Where is Tollo Health's headquarters located?

Minus sign iconPlus sign icon
Tollo Health's main headquarters is located at 40 Wall Street Suite 2702 New York, New York 10005 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Tollo Health's phone number?

Minus sign iconPlus sign icon
You can contact Tollo Health's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tollo Health's official website and social media links?

Minus sign iconPlus sign icon
Tollo Health's official website is tollohealth.com and has social profiles on LinkedInCrunchbase.

What is Tollo Health's SIC code NAICS code?

Minus sign iconPlus sign icon
Tollo Health's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tollo Health have currently?

Minus sign iconPlus sign icon
As of February 2026, Tollo Health has approximately 6 employees across 2 continents, including North AmericaAsia. Key team members include Cto: U. Z.Vice President Clinical Laboratory Services & Business Development: A. B.Marketing Manager: S. J.. Explore Tollo Health's employee directory with LeadIQ.

What industry does Tollo Health belong to?

Minus sign iconPlus sign icon
Tollo Health operates in the Biotechnology Research industry.

What technology does Tollo Health use?

Minus sign iconPlus sign icon
Tollo Health's tech stack includes WordPressRSSGoogle Fonts APIJSON-LDjQuery MigratePriority HintsPHPApache.

What is Tollo Health's email format?

Minus sign iconPlus sign icon
Tollo Health's email format typically follows the pattern of First.L@todosmedical.com. Find more Tollo Health email formats with LeadIQ.

How much funding has Tollo Health raised to date?

Minus sign iconPlus sign icon
As of February 2026, Tollo Health has raised $3.4M in funding. The last funding round occurred on Jan 25, 2021 for $3.4M.

When was Tollo Health founded?

Minus sign iconPlus sign icon
Tollo Health was founded in 2010.

Tollo Health

Biotechnology ResearchNew York, United States2-10 Employees

Founded in Rehovot, Israel with offices in New York City, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company's state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer's influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos' two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe. Todos recently acquired U.S.-based medical diagnostics company Provista Diagnostics, Inc. to gain rights to its Alpharetta, Georgia-based CLIA/CAP certified lab currently performing PCR COVID testing and Provista's proprietary commercial-stage Videssa® breast cancer blood test.

Todos is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer's disease. The Lymphocyte Proliferation Test (LymPro Test™) is a diagnostic blood test that determines the ability of peripheral blood lymphocytes (PBLs) and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle. It is believed that certain diseases, most notably Alzheimer's disease, are the result of compromised cellular machinery that leads to aberrant cell cycle re-entry by neurons, which then leads to apoptosis. LymPro is unique in the use of peripheral blood lymphocytes as a surrogate for neuronal cell function, suggesting a common relationship between PBLs and neurons in the brain.

Todos has entered into distribution agreements with companies to distribute certain novel coronavirus (COVID-19) test kits. The agreements cover multiple international suppliers of PCR testing kits and related materials and supplies, as well as antibody testing kits from multiple manufacturers after completing validation of said testing kits and supplies.

Section iconCompany Overview

Headquarters
40 Wall Street Suite 2702 New York, New York 10005 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
2-10

Section iconFunding & Financials

  • $3.4M

    Tollo Health has raised a total of $3.4M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2021 in the amount of $3.4M.

  • $1M

    Tollo Health's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $3.4M

    Tollo Health has raised a total of $3.4M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2021 in the amount of $3.4M.

  • $1M

    Tollo Health's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.